Receptor-mediated PLGA nanoparticles for glioblastoma multiforme treatment.
- DOI
- 10.1016/j.ijpharm.2018.04.062
- Published
- 2018 Jul 10
- Container
- International journal of pharmaceutics
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ijpharm.2018.04.062,
title = {Receptor-mediated PLGA nanoparticles for glioblastoma multiforme treatment.},
author = {Ramalho MJ and Sevin E and Gosselet F and Lima J and Coelho MAN and Loureiro JA and Pereira MC},
year = {2018},
journal = {International journal of pharmaceutics},
doi = {10.1016/j.ijpharm.2018.04.062},
url = {https://doi.org/10.1016/j.ijpharm.2018.04.062}
}RIS
TY - JOUR TI - Receptor-mediated PLGA nanoparticles for glioblastoma multiforme treatment. AU - Ramalho MJ AU - Sevin E AU - Gosselet F AU - Lima J AU - Coelho MAN AU - Loureiro JA AU - Pereira MC PY - 2018 JO - International journal of pharmaceutics DO - 10.1016/j.ijpharm.2018.04.062 UR - https://doi.org/10.1016/j.ijpharm.2018.04.062 ER -
APA
MJ, R., E, S., F, G., J, L., MAN, C., JA, L., & MC, P. (2018). Receptor-mediated PLGA nanoparticles for glioblastoma multiforme treatment.. International journal of pharmaceutics. https://doi.org/10.1016/j.ijpharm.2018.04.062
Source records
- pubmed · retrieved 2026-09-26T18:22:34.953Z